Increased erythropoietin-α dose when switching from subcutaneous to intravenous administration: Effect of serum albumin

Clinical Nephrology

Volumn 69, Issue 5, 2008, Pages 347-353

  Chen, H H ^a,c,d   Tarng, D Ch ^b   Wu, Ch J ^a,c,d   Chen, Y W ^a   Ting, J T ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Administration route; Albumin; Epoetin; Erythropoietin; Hemodialysis

Indexed keywords

ALBUMIN; FERRITIN; IRON SACCHARATE; PARATHYROID HORMONE; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CHRONIC KIDNEY FAILURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HEMODIALYSIS; HUMAN; LOADING DRUG DOSE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PROSPECTIVE STUDY; TAIWAN; TRANSFERRIN BLOOD LEVEL;

EID: 43449121898     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp69347     Document Type: Article

References (19)